SCHEMBL18800468

SCHEMBL18800468

COc1cccc(-c2cnc(Nc3ccccc3C)c(N)c2C(=N)N)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 4/20 0.49
▸ ADORA2A P29274 1/20 0.46
▸ ADORA1 P30542 1/20 0.46
▸ HSD17B10 Q99714 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ DHODH Q02127 2/20 0.40
▸ SRC P12931 3/20 0.40
▸ TDO2 P48775 1/20 0.39
▸ PDE11A Q9HCR9 1/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ PDGFRA P16234 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800466 0.90 DHODH (0.42) BTKADORA2AADORA1HSD17B10CYP1A2
SCHEMBL18800792 0.90 BTK (0.47) BTKADORA2AADORA1MAPTDHODH
SCHEMBL18800891 0.89 BTK (0.62) BTKADORA2AADORA1MAPTRXFP1
SCHEMBL18800760 0.89 BTK (0.61) BTKADORA2AADORA1HSD17B10CYP1A2
SCHEMBL18800559 0.89 BTK (0.58) BTKMAPK1MAPTSRCPDE11A
SCHEMBL18800784 0.89 BTK (0.46) BTKADORA2AADORA1DHODH
SCHEMBL18800563 0.87 BTK (0.58) BTKADORA2AADORA1HSD17B10CYP1A2
SCHEMBL18800772 0.87 ADORA1 (0.43) BTKADORA1HSD17B10MAPTSRC
SCHEMBL18800558 0.86 BTK (0.43) BTKHSD17B10PDE11AALDH1A1LMNA
SCHEMBL18800786 0.86 RAPGEF4 (0.44) BTKADORA2AADORA1HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback